| The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis Y Zhang, B Heym, B Allen, D Young, S Cole Nature 358 (6387), 591-593, 1992 | 1846 | 1992 |
| O2⋅− and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate JD Schoenfeld, ZA Sibenaller, KA Mapuskar, BA Wagner, ... Cancer cell 31 (4), 487-500. e8, 2017 | 420 | 2017 |
| Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism BG Allen, SK Bhatia, CM Anderson, JM Eichenberger-Gilmore, ... Redox biology 2, 963-970, 2014 | 363 | 2014 |
| Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts BG Allen, SK Bhatia, JM Buatti, KE Brandt, KE Lindholm, AM Button, ... Clinical Cancer Research 19 (14), 3905-3913, 2013 | 257 | 2013 |
| Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: the University of Iowa experience of two phase 1 … A Zahra, MA Fath, E Opat, KA Mapuskar, SK Bhatia, DC Ma, SNR Iii, ... Radiation research 187 (6), 743-754, 2017 | 148 | 2017 |
| Transgenic Xenopus laevis embryos can be generated using φC31 integrase BG Allen, DL Weeks Nature methods 2 (12), 975-979, 2005 | 139 | 2005 |
| Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 130 | 2022 |
| 3D fully convolutional networks for co-segmentation of tumors on PET-CT images Z Zhong, Y Kim, L Zhou, K Plichta, B Allen, J Buatti, X Wu 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018 …, 2018 | 109 | 2018 |
| Pharmacological ascorbate radiosensitizes pancreatic cancer J Du, JA Cieslak III, JL Welsh, ZA Sibenaller, BG Allen, BA Wagner, ... Cancer research 75 (16), 3314-3326, 2015 | 109 | 2015 |
| Enhancement of radiation response in breast cancer stem cells by inhibition of thioredoxin-and glutathione-dependent metabolism SN Rodman, JM Spence, TJ Ronnfeldt, Y Zhu, SR Solst, RA O'Neill, ... Radiation research 186 (4), 385-395, 2016 | 104 | 2016 |
| Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease KA Mapuskar, H Wen, DG Holanda, P Rastogi, E Steinbach, R Han, ... Redox biology 20, 98-106, 2019 | 99 | 2019 |
| Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer MS Alexander, JG Wilkes, SR Schroeder, GR Buettner, BA Wagner, J Du, ... Cancer research 78 (24), 6838-6851, 2018 | 97 | 2018 |
| Radioresistance in Glioblastoma and the Development of Radiosensitizers MY Ali, CR Oliva, ASM Noman, BG Allen, PC Goswami, Y Zakharia, ... Cancers 12 (9), 2511, 2020 | 94 | 2020 |
| Deep segmentation networks predict survival of non-small cell lung cancer S Baek, Y He, BG Allen, JM Buatti, BJ Smith, L Tong, Z Sun, J Wu, ... Scientific reports 9 (1), 17286, 2019 | 92 | 2019 |
| Simultaneous cosegmentation of tumors in PET‐CT images using deep fully convolutional networks Z Zhong, Y Kim, K Plichta, BG Allen, L Zhou, J Buatti, X Wu Medical physics 46 (2), 619-633, 2019 | 88 | 2019 |
| Multi-institutional experience of stereotactic ablative radiation therapy for stage I small cell lung cancer V Verma, CB Simone II, PK Allen, SR Gajjar, C Shah, W Zhen, ... International Journal of Radiation Oncology* Biology* Physics 97 (2), 362-371, 2017 | 82 | 2017 |
| Phase 1b/2a trial of the superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma CM Anderson, ST Sonis, CM Lee, D Adkins, BG Allen, W Sun, ... International Journal of Radiation Oncology* Biology* Physics 100 (2), 427-435, 2018 | 79 | 2018 |
| Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma BR O'Leary, MA Fath, AM Bellizzi, JE Hrabe, AM Button, BG Allen, ... Clinical Cancer Research 21 (7), 1741-1751, 2015 | 73 | 2015 |
| First-in-human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma BG Allen, KL Bodeker, MC Smith, V Monga, S Sandhu, R Hohl, T Carlisle, ... Clinical cancer research 25 (22), 6590-6597, 2019 | 55 | 2019 |
| Pharmacological ascorbate as a means of sensitizing cancer cells to radio-chemotherapy while protecting normal tissue JD Schoenfeld, MS Alexander, TJ Waldron, ZA Sibenaller, DR Spitz, ... Seminars in radiation oncology 29 (1), 25-32, 2019 | 55 | 2019 |
